Rhythm Pharmaceuticals Income Statement (2016-2025) | RYTM

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2016	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue															0.04M	0.27M	1.03M	1.82M	1.50M	9.07M	4.28M	8.79M	11.47M	19.22M	22.50M	24.23M	25.97M	29.08M	33.25M	41.83M	32.70M	48.50M	51.30M
Cost of Revenue															0.00M	0.14M	0.22M	0.24M	0.23M	0.38M	0.50M	1.03M	1.42M	2.24M	2.41M	3.23M	2.81M	2.95M	3.83M	3.79M	3.65M	5.54M	5.50M
Gross Profit															0.03M	0.14M	0.81M	1.58M	1.27M	8.69M	3.79M	7.76M	10.05M	16.98M	20.09M	21.00M	23.16M	26.13M	29.42M	38.04M	29.06M	42.96M	45.80M
Operating items
Research & Development												22.50M	23.00M		19.91M	25.10M	27.54M	31.57M	32.51M	31.46M	21.12M	23.55M	37.95M	33.54M	33.57M	29.89M	128.66M	30.19M	37.93M	41.17M	36.97M	42.31M	46.03M
Selling, General & Administrative												12.80M	8.92M		14.52M	15.46M	17.51M	21.00M	21.45M	22.33M	21.94M	26.32M	24.63M	30.05M	30.48M	32.37M	34.38M	36.41M	35.38M	38.13M	39.09M	45.95M	52.42M
Other Operating Expenses	8.38M		10.98M				27.15M				34.22M				0.00M	0.14M	0.22M	0.24M	0.23M	0.38M	0.50M	1.03M	1.42M	2.24M	2.41M	3.23M	2.81M	2.95M	3.83M	3.79M	3.65M	5.54M	5.50M
Operating Expenses	8.38M		10.98M				27.15M				34.22M	35.30M	31.92M		34.43M	40.71M	45.27M	52.81M	54.19M	54.16M	43.55M	50.89M	64.00M	65.83M	66.46M	65.50M	165.85M	69.56M	77.14M	83.08M	79.71M	93.80M	103.95M
Operating Income												-35.30M	-31.92M		-34.40M	-40.43M	-44.24M	-50.99M	-52.69M	-45.10M	-39.27M	-42.10M	-52.53M	-46.60M	-43.95M	-41.27M	-139.89M	-40.48M	-43.88M	-41.26M	-47.00M	-45.30M	-52.65M
EBIT												-35.30M	-31.92M		-34.40M	-40.43M	-44.24M	-50.99M	-52.69M	-45.10M	-39.27M	-42.10M	-52.53M	-46.60M	-43.95M	-41.27M	-139.89M	-40.48M	-43.88M	-41.26M	-47.00M	-45.30M	-52.65M
Non-operating items
Interest & Investment Income												1.14M	0.80M		0.15M	0.02M	0.14M	0.13M	0.16M	0.27M	0.92M	3.04M	3.44M	3.22M	3.47M	3.82M	3.05M	4.10M	4.05M	3.52M	3.64M	3.24M	4.33M
Other Non Operating Income															100.00M				-0.23M	-0.13M	-0.37M	-0.42M	-0.03M	-0.02M	-0.16M	0.56M	0.52M	8.90M	1.09M		-0.64M	1.58M	0.27M
Non Operating Income	0.01M		0.45M				1.64M				1.27M	1.14M	0.80M		100.15M	0.02M	0.14M	0.13M	-0.23M	-0.13M	-1.59M	-0.39M	0.35M	-0.10M	-0.16M	-0.17M	-1.19M	8.70M	1.09M	-2.13M	-2.41M	1.58M	0.27M
Net income details
EBT												-34.16M	-31.12M		65.76M	-40.41M	-44.10M	-50.85M	-52.53M	-44.82M	-40.86M	-42.49M	-52.18M	-46.70M	-43.80M	-41.44M	-141.07M	-31.78M	-43.98M	-43.38M	-49.42M	-46.30M	-52.79M
Tax Provisions															22.01M	-5.02M	-8.99M								0.37M	0.20M	0.30M	0.50M	-0.34M	-0.09M	0.08M	0.34M	0.11M
Profit After Tax	-8.37M		-10.53M				-25.51M				-32.96M	-34.16M	-31.12M		65.76M	-40.41M	-44.10M	-42.87M	-52.76M	-45.00M	-40.86M	-42.49M	-52.18M	-46.70M	-44.16M	-41.63M	-141.37M	-32.26M	-43.64M	-43.29M	-49.50M	-46.63M	-52.90M
Income from Continuing Operations												-34.16M	-31.12M		43.75M	-35.39M	-35.11M	-50.85M	-52.53M	-44.82M	-40.86M	-42.49M	-52.18M	-46.70M	-44.16M	-41.63M	-141.37M	-32.28M	-43.64M	-43.29M	-49.50M	-46.63M	-52.90M
Consolidated Net Income												-34.16M	-31.12M		43.75M	-35.39M	-35.11M	-50.85M	-52.53M	-44.82M	-40.86M	-42.49M	-52.18M	-46.70M	-44.16M	-41.63M	-141.37M	-32.28M	-43.64M	-43.29M	-49.50M	-46.63M	-52.90M
Income towards Parent Company												-34.16M	-31.12M		43.75M	-35.39M	-35.11M	-50.85M	-52.53M	-44.82M	-40.86M	-42.49M	-52.18M	-46.70M	-44.16M	-41.63M	-141.37M	-32.28M	-43.64M	-43.29M	-49.50M	-46.63M	-52.90M
Net Income towards Common Stockholders												-34.16M	-31.12M		43.75M	-35.39M	-35.11M	-50.85M	-52.53M	-44.82M	-40.86M	-42.49M	-52.18M	-52.18M	-44.16M	-41.63M	-141.37M	-33.56M	-44.97M	-44.63M	-50.82M	-47.98M	-54.28M
Additional items
EPS (Basic)	-0.90		-0.41				-0.74				-0.78	-0.78	-0.71		0.92	-0.70	-0.70	-0.86	-1.05	-0.89	-0.79	-0.74	-0.92	-0.82	-0.76	-0.70	-2.35	-0.55	-0.73	-0.72	-0.81	-0.75	-0.82
EPS (Weighted Average and Diluted)												-0.78	-0.71		0.90	-0.70	-0.70	-0.86	-1.05	-0.89	-0.79	-0.74	-0.92	-0.82	-0.76	-0.70	-2.35	-0.55	-0.73	-0.72	-0.81	-0.75	-0.82
Shares Outstanding (Weighted Average)		27.13M	27.28M	27.28M	27.53M	34.18M	34.41M	34.43M	34.43M	34.52M	43.93M	44.06M	44.09M	44.12M	50.18M	50.21M	50.23M	50.27M	50.33M	50.39M	50.72M	56.35M	56.75M	56.85M	56.90M	59.10M	60.14M	60.97M	61.13M	61.46M	63.22M	63.62M	66.42M
Shares Outstanding (Diluted Average)											36.42M	44.05M	44.10M		48.50M	50.21M	50.25M	49.60M	50.33M	50.40M	51.40M	52.12M	56.71M	56.87M	57.87M	57.67M	60.14M	61.01M	61.22M	61.00M	63.06M	63.68M	66.26M
EBITDA												-35.30M	-31.92M		-34.40M	-40.43M	-44.24M	-50.99M	-52.69M	-45.10M	-39.27M	-42.10M	-52.53M	-46.60M	-43.95M	-41.27M	-139.89M	-40.48M	-43.88M	-41.26M	-47.00M	-45.30M	-52.65M
Interest Expenses																					2.14M	3.01M	3.06M	3.30M	3.15M	4.55M	4.75M	4.60M	5.24M	5.45M	5.41M	5.82M	4.74M
Tax Rate															33.47%	12.43%	20.40%												0.78%	0.21%

Research Tools

Rhythm Pharmaceuticals Income Statement (2016-2025) | RYTM

Create an account

Sign In

Reset Password

Get Pro for 60% off